Ocular Therapeutix, Inc.
OCUL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,351,583 | $356,030 | $216,019 | $532,458 |
| - Cash | $392,102 | $195,807 | $102,300 | $164,164 |
| + Debt | $75,783 | $83,389 | $64,283 | $58,983 |
| Enterprise Value | $1,035,264 | $243,612 | $178,002 | $427,277 |
| Revenue | $63,723 | $58,443 | $51,494 | $43,522 |
| % Growth | 9% | 13.5% | 18.3% | – |
| Gross Profit | $58,097 | $53,162 | $46,954 | $39,116 |
| % Margin | 91.2% | 91% | 91.2% | 89.9% |
| EBITDA | -$176,143 | -$66,415 | -$61,907 | $2,539 |
| % Margin | -276.4% | -113.6% | -120.2% | 5.8% |
| Net Income | -$193,506 | -$80,736 | -$71,038 | -$6,553 |
| % Margin | -303.7% | -138.1% | -138% | -15.1% |
| EPS Diluted | -1.22 | -1.02 | -0.97 | -0.98 |
| % Growth | -19.6% | -5.2% | 1% | – |
| Operating Cash Flow | -$134,677 | -$70,234 | -$59,603 | -$65,550 |
| Capital Expenditures | -$1,288 | -$6,087 | -$3,715 | -$1,194 |
| Free Cash Flow | -$135,965 | -$76,321 | -$63,318 | -$66,744 |